Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study.
Kocoshis, Samuel A
Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study. [electronic resource] - JPEN. Journal of parenteral and enteral nutrition 05 2020 - 621-631 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1941-2444
10.1002/jpen.1690 doi
Adult
Aged
Child
Child, Preschool
Double-Blind Method
Female
Gastrointestinal Agents--therapeutic use
Humans
Male
Parenteral Nutrition
Peptides--therapeutic use
Short Bowel Syndrome--complications
Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study. [electronic resource] - JPEN. Journal of parenteral and enteral nutrition 05 2020 - 621-631 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1941-2444
10.1002/jpen.1690 doi
Adult
Aged
Child
Child, Preschool
Double-Blind Method
Female
Gastrointestinal Agents--therapeutic use
Humans
Male
Parenteral Nutrition
Peptides--therapeutic use
Short Bowel Syndrome--complications